Клинический случай применения омализумаба в базисной терапии персистирующей бронхиальной астмы тяжелого течения
2014
The article presents results of clinical observation of a patient with severe persistent allergic asthma treated with omalizumab. Omalizumab is a treatment option for patients with moderate to severe allergic asthma in cases when the symptoms are poorly controlled with inhaled corticosteroids. Treatment with omalizumab resulted in improvement of both the disease symptoms and respiratory function indicators. It is concluded that the addition of omalizumab decreases the doses of corticosteroids and allows to achieve control over the disease.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI